Cytomegalovirus-induced immunopathology and its clinical consequences
Open Access
- 1 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Herpesviridae
- Vol. 2 (1), 6
- https://doi.org/10.1186/2042-4280-2-6
Abstract
Human cytomegalovirus (CMV) is a ubiquitous DNA virus that causes severe disease in patients with immature or impaired immune systems. During active infection, CMV modulates host immunity, and CMV-infected patients often develop signs of immune dysfunction, such as immunosuppression and autoimmune phenomena. Furthermore, active viral infection has been observed in several autoimmune diseases, and case reports have linked primary CMV infection and the onset of autoimmune disorders. In addition, CMV infection promotes allograft rejection and graft-versus-host disease in solid organ and bone marrow transplant recipients, respectively, further implicating CMV in the genesis and maintenance of immunopathological phenomena. The mechanisms by which CMV could induce inhibition of host defense, inflammation, and autoimmunity are discussed, as is the treatment of virus-induced immunopathology with antivirals.Keywords
This publication has 151 references indexed in Scilit:
- Cytomegalovirus Infection in Patients Who Required Colectomy for Toxic Megacolon or Severe Steroid-Refractory Ulcerative ColitisDigestive Diseases and Sciences, 2010
- Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung TransplantationClinical Infectious Diseases, 2008
- Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cellsThe Journal of Experimental Medicine, 2008
- Acceleration of allograft failure by cytomegalovirusCurrent Opinion in Immunology, 2007
- Latent Epstein–Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridizationLaboratory Investigation, 2004
- Consequences of human cytomegalovirus mimicryHuman Immunology, 2004
- Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitisBritish Journal of Dermatology, 2003
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- The Immediate Early Gene Products of Human Cytomegalovirus Increase Vascular Smooth Muscle Cell Migration, Proliferation, and Expression of PDGF β-ReceptorBiochemical and Biophysical Research Communications, 1999
- Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantationJournal of Medical Virology, 1987